Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
/
Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Braskem S.A. - ADR represents American Depositary Receipts for Braskem S.A., a leading global petrochemical company headquartered in São Paulo, Brazil. Braskem stands as the largest petrochemical operation in Latin America and is among Brazil’s top private industrial enterprises. The company specializes in the manufacture and sale of a broad spectrum of chemicals, fuels, and thermoplastic resins, including polyethylene, polypropylene, and polyvinyl chloride, essential to industries such as packaging, automotive, construction, and consumer goods. Braskem operates extensive industrial facilities across Brazil, with additional presence in the United States, Mexico, Europe, and Asia, facilitating a wide international reach. Its portfolio also covers the supply of utilities—such as electricity, steam, and industrial gases—and services to other manufacturers in the chemical supply chain. Braskem’s significance in the market stems from its role as a core supplier of foundational petrochemicals, supporting diverse sectors and contributing to the stability and growth of the chemical industry worldwide.
BRL 2.67
BRL 0.26 (-8.87%)
EOD Jun 25, 2026 · Twelve Data
The business is unprofitable at the operating level (-2.32% margin). The thesis depends entirely on whether and when it reaches sustainable profitability.
Revenue declined 8.6% YoY. Margins deteriorated 3.5pp alongside, both lines moving the wrong way.
ROIC dropped from 1.04% to -1.79%, capital efficiency is deteriorating. Negative free cash flow of -BRL 7.33B. The business is consuming cash, not generating it.
Based on TTM earnings · Diluted shares
Profitability & Returns
Revenue (TTM)
BRL 66.75B
▼ -8.6% YoY
Net Income (TTM)
-BRL 10.35B
▲ +9.1% YoY
Op. Margin
-2.79%
▼ -3.5pp YoY
ROIC
-1.79%
▼ -2.8pp YoY
Cash Flow & Balance Sheet
FCF (TTM)
-BRL 9.27B
▼ -452.9% YoY
Op. Cash Flow (TTM)
-BRL 4.10B
▼ -122.7% YoY
Net Debt
BRL 59.48B
Cash & Equiv.
BRL 11.84B
3Y CAGR: -9.8%
Continue Research
Braskem S.A. - ADR (BAK)'s valuation is best read against its own history, its peers, and the growth its price implies. A high multiple is not the same as overvalued: fast-growing, high-quality businesses can deserve a premium. See the general approach in how to tell if a stock is overvalued.
On quality, Braskem S.A. - ADR scores 10/100 on Intrinsiqq's quality scorecard (a lower-quality business on these measures), weighing growth, margins, returns on capital, share count, and balance-sheet strength. All figures are computed from SEC filings; read the full . This is analysis, not investment advice.
Braskem S.A. - ADR scores 10 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which makes it a lower-quality business on these measures. Recent fundamentals include a -2.8% operating margin and a -1.8% return on invested capital. The score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, share-count change, and balance-sheet strength, all computed from SEC filings, not opinion. Because valuation only means something relative to quality, the full metric-by-metric breakdown is on the quality scorecard.
That depends on valuation and quality together, not either alone. you should weigh BAK's valuation and scores 10/100 on quality (lower-quality). A cheap price is only a bargain if the business is durable, and a premium can be justified by genuine quality, so the two questions, "is it cheap?" and "is it good?", only make sense side by side. Read the valuation against the quality scorecard, run the DCF on your own assumptions, and decide for yourself. This is analysis from SEC filings, not investment advice.